Triiodothyronine (T3 / FT3)

Clinical interpretation, reference ranges, and thyroid status evaluation for Triiodothyronine (T3/FT3) under ATA 2017 standards.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

Specimen TypeVenous Blood (Serum)
PreparationFasting optional unless ordered with lipid panel
Turnaround Time24–48 Hours
Clinical CategoryThyroid

Laboratory Interpretation Workflow

Stage 1 of 5

1. Clinical Indication

Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.

Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.

Test Description & Overview

Triiodothyronine (T3): The active metabolic thyroid hormone produced predominantly via 5'-deiodination of Thyroxine (T4) in peripheral tissues (80%) and direct thyroid follicular secretion (20%). Free T3 (FT3) measures the metabolically active unbound fraction.

Standard Reference Range

Free T3 (FT3): 2.0 - 4.4 pg/mL (3.1 - 6.8 pmol/L); Total T3: 80 - 200 ng/dL (1.2 - 3.1 nmol/L).

Elevated (High) Values

  • Hyperthyroidism (Graves' Disease, Toxic Multinodular Goiter)
  • T3 Toxicosis (Elevated T3 with Suppressed TSH and Normal T4)
  • Thyroid Hormone Resistance or Exogenous Liothyronine Administration

Decreased (Low) Values

  • Euthyroid Sick Syndrome (Non-Thyroidal Illness Syndrome / Low T3 Syndrome)
  • Hypothyroidism (Primary or Secondary)
  • Severe Malnutrition, Starvation, or Systemic Catabolic State

Clinical Alignment & Significance

Elevated FT3 with suppressed TSH indicates hyperthyroidism or T3 toxicosis; in severe systemic non-thyroidal illness, low FT3 reflects impaired peripheral T4-to-T3 5'-deiodination (Euthyroid Sick Syndrome) rather than primary thyroid failure.

Diagnostic Guidance Notice

Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0068Alexander E. K., Pearce E. N., Brent G. A.. "2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum." Thyroid (2017).DOI PubMed
Clinical Reviews & Textbooks
  • CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).

AI & Generative Search Citation Block

Entity IDL0010
Entity Typelab-test
Content Versionv1.1.0
Last Reviewed DateJul 31, 2026
Evidence LevelTraditional-Literature
Suggested Academic/LLM Citation format (AMA Style)

Dr. Narayan Jethwani. "Triiodothyronine (T3 / FT3)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T19:50:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/t3

No clinical connections registered for this topic.

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.